AXIM BIOTECHNOLOGIES, INC.: 10-Q filed 2022-08-16

Name: AXIM BIOTECHNOLOGIES, INC.: 10-Q filed 2022-08-16
Creator: AXIM BIOTECHNOLOGIES, INC.

What AXIM BIOTECHNOLOGIES, INC. reported in its quarterly report filed 2022-08-16 (fiscal Q2 2022): 38 published measures, 112 facts as tagged in accession 0001096906-22-001922.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-08-16
Fiscal period: fiscal Q2 2022
Accession: 0001096906-22-001922 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AXIM BIOTECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-06-30	4,521,056	USD
At 2021-12-31	5,323,435	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-06-30	8,254,118	USD
At 2021-12-31	7,661,635	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-06-30	-3,733,062	USD
At 2022-03-31	-3,423,683	USD
At 2021-12-31	-2,338,200	USD
At 2021-06-30	1,037,600	USD
At 2021-03-31	1,628,528	USD
At 2020-12-31	1,565,821	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2022-06-30	65,163	USD
At 2021-12-31	452,963	USD
At 2021-06-30	202,185	USD
At 2020-12-31	457,181	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-1,222,638	USD	91
2022-01-01 to 2022-06-30	-3,309,354	USD	181
2022-01-01 to 2022-03-31	-2,086,714	USD	90
2021-04-01 to 2021-06-30	-3,826,921	USD	91
2021-01-01 to 2021-06-30	-4,691,457	USD	181
2021-01-01 to 2021-03-31	-864,536	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-1,407,596	USD	181
2021-01-01 to 2021-06-30	-1,160,993	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	0	USD	91
2022-01-01 to 2022-06-30	0	USD	181
2021-04-01 to 2021-06-30	14,875	USD	91
2021-01-01 to 2021-06-30	47,524	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	1,025,796	USD	181
2021-01-01 to 2021-06-30	926,019	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	-6,000	USD	181
2021-01-01 to 2021-06-30	-20,022	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-06-30	-61,191,579	USD
At 2021-12-31	-57,882,227	USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-0.01	USD/shares	91
2022-01-01 to 2022-06-30	-0.01	USD/shares	181
2021-04-01 to 2021-06-30	-0.03	USD/shares	91
2021-01-01 to 2021-06-30	-0.04	USD/shares	181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-0.01	USD/shares	91
2022-01-01 to 2022-06-30	-0.01	USD/shares	181
2021-04-01 to 2021-06-30	-0.03	USD/shares	91
2021-01-01 to 2021-06-30	-0.04	USD/shares	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2022-04-01 to 2022-06-30	USD	91
2022-01-01 to 2022-06-30	USD	181
2021-04-01 to 2021-06-30	USD	91
2021-01-01 to 2021-06-30	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2022-06-30	107,491	USD
At 2021-12-31	116,810	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	371,133	USD	181
2021-01-01 to 2021-06-30	191,266	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-1,059,893	USD	91
2022-01-01 to 2022-06-30	-2,168,830	USD	181
2021-04-01 to 2021-06-30	-2,181,038	USD	91
2021-01-01 to 2021-06-30	-3,049,038	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-06-30	173,173	USD
At 2021-12-31	636,613	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	60,176	USD	91
2022-01-01 to 2022-06-30	1,582,825	USD	181
2021-04-01 to 2021-06-30	59,576	USD	91
2021-01-01 to 2021-06-30	119,908	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-06-30	2,711,502	USD
At 2021-12-31	2,580,994	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	1,059,893	USD	91
2022-01-01 to 2022-06-30	2,168,830	USD	181
2021-04-01 to 2021-06-30	2,195,913	USD	91
2021-01-01 to 2021-06-30	3,096,562	USD	181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2022-06-30	20,089	USD
At 2021-12-31	20,089	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	918,708	USD	91
2022-01-01 to 2022-06-30	1,876,915	USD	181
2021-04-01 to 2021-06-30	1,499,917	USD	91
2021-01-01 to 2021-06-30	2,293,263	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	35,171	USD	91
2022-01-01 to 2022-06-30	79,364	USD	181
2021-04-01 to 2021-06-30	48,066	USD	91
2021-01-01 to 2021-06-30	149,019	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-06-30	138,099,981	shares
At 2021-12-31	138,099,981	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-06-30	57,399,438	USD
At 2021-12-31	51,000,166	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-06-30	48,742	USD
At 2021-12-31	76,871	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2022-06-30	181,282	USD
At 2021-12-31	175,283	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2022-06-30	73,791	USD
At 2021-12-31	58,473	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-06-30	0	USD
At 2021-12-31	1,701	USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

Period	Value	Unit	Days
At 2022-06-30	0	USD
At 2021-12-31	0	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	-1,222,638	USD	91
2022-01-01 to 2022-06-30	-3,309,354	USD	181
2021-04-01 to 2021-06-30	-3,826,921	USD	91
2021-01-01 to 2021-06-30	-4,686,824	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	7,402	USD	91
2022-01-01 to 2022-06-30	15,318	USD	181
2021-04-01 to 2021-06-30	6,834	USD	91
2021-01-01 to 2021-06-30	13,184	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	98,612	USD	91
2022-01-01 to 2022-06-30	197,223	USD	181
2021-04-01 to 2021-06-30	641,096	USD	91
2021-01-01 to 2021-06-30	641,096	USD	181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2022-04-01 to 2022-06-30	162,745	USD	91
2022-01-01 to 2022-06-30	1,140,524	USD	181
2021-04-01 to 2021-06-30	1,645,883	USD	91
2021-01-01 to 2021-06-30	1,637,786	USD	181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	0	USD	181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	0	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	-11,872	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-06-30	0	USD	181
2021-01-01 to 2021-06-30	-20,509	USD	181

Inspect the source

Entity: AXIM BIOTECHNOLOGIES, INC. / CIK 0001514946
Captured: 2026-09-20T09:13:30.666Z
SEC response SHA-256: 5755093e2dfb1c20119737eacb251a5ef040e09cdc537c89d6edf9272249749e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001514946.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))